NEW YORK, June 22 - Rubicon Genomics has appointed Thomas Collet, a former health care venture capitalist, to lead the company as president and chief executive officer, the company said Friday.
NEW YORK, June 22 - Rubicon Genomics has appointed Thomas Collet, a former health care venture capitalist, to lead the company as president and chief executive officer, the company said Friday.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.